Influence of pore size on the redifferentiation potential of human articular chondrocytes in poly(urethane urea) scaffolds

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 7, 2011, Pages 578-588

  Stenhamre, H ^a,b   Nannmark, U ^c   Lindahl, A ^b   Gatenholm, P ^a   Brittberg, M ^c  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Chondrocytes; Neocartilage formation; Redifferentiation; Scaffold architecture

Indexed keywords

ARCHITECTURE; BODY FLUIDS; CARTILAGE; ESTERS; METABOLISM; SCAFFOLDS (BIOLOGY); UREA;

CHONDROCYTES; HUMAN ARTICULAR CHONDROCYTES; IN-VITRO; NEOCARTILAGE; NEOCARTILAGE FORMATION; PERFORMANCE; POLY(URETHANE UREA); POLYURETHANE (UREA); REDIFFERENTIATION; SCAFFOLD ARCHITECTURE;

PORE SIZE;

HYALIN; POLY(URETHANE UREA); POLYMER; POLYURETHAN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTICULAR CARTILAGE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL FUNCTION; CHONDROGENESIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; PHYSICAL CHEMISTRY; POROSITY; PRIORITY JOURNAL; TISSUE ENGINEERING;

EID: 79959498878     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.350     Document Type: Article

References (45)

1. Boyan BD, Hummert TW, Dean DD, et al. 1996; Role of material surfaces in regulating bone and cartilage cell response. Biomaterials 17: 137-146.
2. Brittberg M, Lindahl A, Nilsson A, et al. 1994; Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889-895.
3. Concaro S, Nicklasson E, Ellowsson L, et al. 2008; Effect of cell seeding concentration on the quality of tissue engineered constructs loaded with adult human articular chondrocytes. J Tissue Eng Regen Med 2: 14-21.
4. Coutts RD, Healey RM, Ostrander R, et al. 2001; Matrices for cartilage repair. Clin Orthop Relat Res 391: S271-S279.
5. DeLise AM, Fischer L, Tuan RS. 2000; Cellular interactions and signaling in cartilage development. Osteoarthr Cartilage 8: 309-334.
6. Diaz-Romero J, Gaillard JP, Grogan SP, et al. 2005; Immunophenotypic analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture. J Cell Physiol 202: 731-742.
7. Domm C, Schunke M, Steinhagen J, et al. 2004; Influence of various alginate brands on the redifferentiation of dedifferentiated bovine articular chondrocytes in alginate bead culture under high and low oxygen tension. Tissue Eng 10: 1796-1805.
8. Farndale RW, Buttle DJ, Barrett AJ. 1986; Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883: 173-177.
9. Freed LE, Marquis JC, Nohria A, et al. 1993; Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 27: 11-23.
10. Gisselfalt K, Edberg B, Flodin P. 2002; Synthesis and properties of degradable poly(urethane urea)s to be used for ligament reconstructions. Biomacromolecules 3: 951-958.
11. Griffon DJ, Sedighi MR, Schaeffer DV, et al. 2006; Chitosan scaffolds: interconnective pore size and cartilage engineering. Acta Biomater 2: 313-320.
12. Grigolo B, Lisignoli G, Piacentini A, et al. 2002; Evidence for redifferentiation of human chondrocytes grown on a hyaluronan-based biomaterial (HYAff 11): molecular, immunohistochemical and ultrastructural analysis. Biomaterials 23: 1187-1195.
13. Grogan SP, Barbero A, Winkelmann V, et al. 2006; Visual histological grading system for the evaluation of in vitro-generated neocartilage. Tissue Eng 12: 2141-2149.
14. Hayes AJ, Dowthwaite GP, Webster SV, et al. 2003; The distribution of Notch receptors and their ligands during articular cartilage development. J Anat 202: 495-502.
15. Hutmacher DW. 2000; Scaffolds in tissue engineering bone and cartilage. Biomaterials 21: 2529-2543.
16. Jackson DW, Simon TM, Aberman HM. 2001; Symptomatic articular cartilage degeneration: the impact in the new millennium. Clin Orthop Relat Res 391: S14-S25.
17. Kang SW, Yoo SP, Kim BS. 2007; Effect of chondrocyte passage number on histological aspects of tissue-engineered cartilage. Biomed Mater Eng 17: 269-276.
18. Karageorgiou V, Kaplan D. 2005; Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26: 5474-5491.
19. Karlsson C, Jonsson M, Asp J, et al. 2007; Notch and HES5 are regulated during human cartilage differentiation. Cell Tissue Res 327: 539-551.
20. Malda J, van Blitterswijk CA, van Geffen M, et al. 2004; Low oxygen tension stimulates the redifferentiation of dedifferentiated adult human nasal chondrocytes. Osteoarthr Cartilage 12: 306-313.
21. Miot S, Woodfield T, Daniels AU, et al. 2005; Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials 26: 2479-2489.
22. Moretti M, Wendt D, Dickinson SC, et al. 2005; Effects of in vitro preculture on in vivo development of human engineered cartilage in an ectopic model. Tissue Eng 11: 1421-1428.
23. Munirah S, Kim SH, Ruszymah BH, et al. 2008; The use of fibrin and poly(lactic-co-glycolic acid) hybrid scaffold for articular cartilage tissue engineering: an in vivo analysis. Eur Cell Mater 15: 41-52.
24. Nehrer S, Domayer S, Dorotka R, et al. 2006; Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur J Radiol 57: 3-8.
25. Salem AK, Stevens R, Pearson RG, et al. 2002; Interactions of 3T3 fibroblasts and endothelial cells with defined pore features. J Biomed Mater Res 61: 212-217.
26. Schwartz Z, Martin JY, Dean DD, et al. 1996; Effect of titanium surface roughness on chondrocyte proliferation, matrix production, and differentiation depends on the state of cell maturation. J Biomed Mater Res 30: 145-155.
27. Se Heang Oha IKP, Jin Man Kimb, Jin Ho Leea. 2007; In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method. Biomaterials 28: 1664-1671.
28. Stenhamre H, Slynarski K, Petren C, et al. 2008; Topographic variation in redifferentiation capacity of chondrocytes in the adult human knee joint. Osteoarthr Cartilage 16: 1356-1362.
29. Tallheden T, Bengtsson C, Brantsing C, et al. 2005; Proliferation and differentiation potential of chondrocytes from osteoarthritic patients. Arthritis Res Ther 7: R560-568.
30. Tallheden T, Dennis JE, Lennon DP, et al. 2003; Phenotypic plasticity of human articular chondrocytes. J Bone Joint Surg Am 85A(suppl 2): 93-100.
31. Tallheden T, Karlsson C, Brunner A, et al. 2004; Gene expression during redifferentiation of human articular chondrocytes. Osteoarthr Cartilage 12: 525-535.
32. Thomas V, Muthu J. 2008; Biomechanical studies on aliphatic physically crosslinked poly(urethane urea) for blood contact applications. J Mater Sci Mater Med 19: 2721-2733.
33. Thorvaldsson A, Stenhamre H, Gatenholm P, et al. 2008; Electrospinning of highly porous scaffolds for cartilage regeneration. Biomacromolecules 9: 1044-1049.
34. Tognana E, Borrione A, De Luca C, et al. 2007; Hyalograft C: hyaluronan-based scaffolds in tissue-engineered cartilage. Cells Tissues Organs 186: 97-103.
35. van Tienen TGHR, Buma P, de Groot JH, et al. 2002; Tissue ingrowth and degradation of two biodegradable porous polymers with different porosities and pore sizes. Biomaterials 23: 1731-1738.
36. Veilleux NH, Yannas IV, Spector M. 2004; Effect of passage number and collagen type on the proliferative, biosynthetic, and contractile activity of adult canine articular chondrocytes in type I and II collagen-glycosaminoglycan matrices in vitro. Tissue Eng 10: 119-127.
37. Wang Y, Blasioli DJ, Kim HJ, et al. 2006; Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials 27: 4434-4442.
38. Watanabe N, Tezuka Y, Matsuno K, et al. 2003; Suppression of differentiation and proliferation of early chondrogenic cells by Notch. J Bone Miner Metab 21: 344-352.
39. Wisse E, Renken RA, Roosma JR, et al. 2007; Poly(caprolactone-co-oxo-crown ether)-based poly(urethane)urea for soft tissue engineering applications. Biomacromolecules 8: 2739-2745.
40. Woodfield TB, Bezemer JM, Pieper JS, et al. 2002; Scaffolds for tissue engineering of cartilage. Crit Rev Eukaryot Gene Expr 12: 209-236.
41. Yamane S, Iwasaki N, Kasahara Y, et al. 2007; Effect of pore size on in vitro cartilage formation using chitosan-based hyaluronic acid hybrid polymer fibers. J Biomed Mater Res A 81: 586-593.
42. Yang S, Leong KF, Du Z, et al. 2001; The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng 7: 679-689.
43. Zdrahala RJ, Zdrahala IJ. 1999; Biomedical applications of polyurethanes: a review of past promises, present realities, and a vibrant future. J Biomater Appl 14: 67-90.
44. Zeltinger J, Sherwood JK, Graham DA, et al. 2001; Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng 7: 557-572.
45. Zwingmann J, Mehlhorn AT, Sudkamp N, et al. 2007; Chondrogenic differentiation of human articular chondrocytes differs in biodegradable PGA/PLA scaffolds. Tissue Eng 13: 2335-2343.